Recalls / Active ingredient / Nortriptyline Hydrochloride
Nortriptyline Hydrochloride
1 FDA drug recall involving the active ingredient “Nortriptyline Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-01-08 | Class II | Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay | Taro Pharmaceuticals U.S.A., Inc. |